MWNA
SWTX

Marshall Wace North America’s SpringWorks Therapeutics SWTX Stock Holding History

Marshall Wace North America’s Portfolio SWTX Stock Details SWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$10.6M Buy
167,171
+140,114
+518% +$10.8M 0.05% 339
2021
Q2 		$2.23M Buy
+27,057
New +$2.05M 0.01% 774
2020
Q4 		– Sell
-19,752
Closed -$942K – 1573
2020
Q3 		$942K Buy
+19,752
New +$841K 0.01% 823
2019
Q4 		– Sell
-35,761
Closed -$775K – 1586
2019
Q3 		$775K Buy
+35,761
New +$845K ﹤0.01% 740

Other funds holding SWTX

O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return